Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
4-Ethyl-2,3-dioxopiperazinecarbonyl chloride → 1-(1-{4-[(4aS,8aR)-4-(3,4-Dimethoxyphenyl)-1-oxo4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-methanoyl)-4-ethyl-piperazine-2,3-dione
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | 4-Ethyl-2,3-dioxopiperazinecarbonyl chloride | HCID 108813 | — |
| 반응물 | (4aS,8aR)-4-(3,4-Diethoxyphenyl)-2-[1-(toluene-4-sulfonyl)-piperidin-4-yl]-4a,5,8,8a-tetrahydro-2H-phthalazin-1-one | HCID 10175016 | — |
| 생성물 | 1-(1-{4-[(4aS,8aR)-4-(3,4-Dimethoxyphenyl)-1-oxo4a,5,8,8a-tetrahydro-1H-phthalazin-2-yl]-piperidin-1-yl}-methanoyl)-4-ethyl-piperazine-2,3-dione | HCID 9828642 | — |
반응 단계
Prepared from 4-ethyl-2,3-dioxo-piperazine-1-carbonyl chloride and starting compound A1 as described for compound 1. Crystallisation from ethyl acetate/diethyl ether. M.p. 226-228° C.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07531540B2 |
| 출처 데이터셋 | uspto-grants-2009_05 |
| ORD ID | ord-56da14b202404792b32d8c6cf0e2376e |
| 출처 메모 | uspto-grants-2009_05 |